Based in Boston (MA, USA) and France, ImaBiotech offers deep drug investigation services in preclinical to clinical stages, from model validation to patient stratification. The unique proprietary platform combines Spatial Biology and spatial Multi-omics techniques (Mass Spectrometry Imaging, Imaging Mass cytometry, Gene expression) and standard GLP Bioanalytical services for more comprehensive drug efficacy evaluation and more relevant biomarkers identification. To learn more on how ImaBiotech can enhance deliver better preclinical studies, and reduce your time to market, visit www.imabiotech.com